C-1311
Names
[ CAS No. ]:
138154-39-9
[ Name ]:
C-1311
[Synonym ]:
5-[[(diethylamino)ethyl]amino]-8-hydroxyimidazo[4,5,1-de]-acridine-6-one
C 1311
XLS-002
6H-Imidazo(4,5,1-de)acridin-6-one,5-((2-(diethylamino)ethyl)amino)-8-hydroxy
5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo(4,5,1-de)acridin-6-one
Chemical & Physical Properties
[ Density]:
1.32g/cm3
[ Boiling Point ]:
605.8ºC at 760mmHg
[ Molecular Formula ]:
C20H22N4O2
[ Molecular Weight ]:
350.41400
[ Flash Point ]:
320.2ºC
[ Exact Mass ]:
350.17400
[ PSA ]:
69.87000
[ LogP ]:
2.97100
[ Vapour Pressure ]:
2.86E-15mmHg at 25°C
[ Index of Refraction ]:
1.68
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ RIDADR ]:
NONH for all modes of transport
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
J. Pharmacol. Exp. Ther. 346(3) , 393-405, (2013)
Imidazoacridinone 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor inhibitor of topoisomerase II and FMS-like tyrosine kinase 3 receptor. In this study, we describe the uni...
Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use.Drug Metab. Dispos. 41(2) , 414-21, (2013)
The acridinone derivates 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305) and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) are promising antitumor agents with high activ...
Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.J. Pharm. Biomed. Anal. 39(1-2) , 46-53, (2005)
C1311 (5-[[2-(diethylamino)ethyl]amino]-8-hydroxyimidazo [4,5,1-de]-acridin-6-one-dihydrochloride trihydrate) is the lead compound from the group of imidazoacridinones, a novel group of rationally des...